How to stay safe from COVID-19 in the middle of Coachella, spring break
How to stay safe from COVID-19 in the middle of Coachella, spring break

How to stay safe from COVID-19 in the middle of Coachella, spring break

With multiple cases of coronavirus at a modest pace in Los Angeles County, health officials say it is still a good idea to take measures to protect against becoming infected.

Doctors have pointed out that becoming infected continues to pose a risk of long-term COVID, where symptoms of the disease can persist for years, putting people at increased future risk of diabetes and heart disease.

Here are some tips to keep you safer during the spring holidays, Easter holidays and Coachella Valley Music and Arts Festival:

Get updated on your vaccines and boosters

There are still many people in LA County who are eligible for their first booster shot but who have not been boosted.

Among higher-risk individuals, only 74% of vaccinated seniors aged 65 and older who are eligible for a booster shot have received their first booster; the same goes for only 65% ​​of vaccinated adults ages 50 to 64, according to data shared by LA County Public Health Director Barbara Ferrer.

US Centers for Disease Control and Prevention recommend that everyone aged 12 and over receives at least one COVID-19 booster shot after completing the primary vaccination series.

Those aged 50 and over are eligible for another booster shot, as are immunocompromised individuals aged 12 and up.

Make sure the people you spend time with are vaccinated and boosted

Yes, it can be troublesome. However, asking people about their vaccination and booster shot status is especially important when people at higher risk for COVID-19 complications are attending an event.

Goldenvoice repealed all COVID-19 security protocols to the Stagecoach festivals Coachella and country theme that will be held later this month in Indio.

Do not travel or gather if you have symptoms of COVID-19

Some people may dismiss their symptoms as related to allergies – but it may be COVID-19.

Get tested, and regardless of the test result, stay home if you are sick. Sometimes quick tests can show negative test results when there is too little virus in the body to be detected by the test; wait several days later could show a positive test result.

“If you’ve symptomatic, if you have a positive test, you’ll have to go back to using virtual strategies to connect so you’re able to spread some cheers, but you’re not spreading the virus,” Ferrer said.

Take a coronavirus test if you want to be around high-risk people

If you want to be with others at higher risk for serious illness, Ferrer said, “it’s really important to go ahead and take that COVID-19 test before you meet them.”

And if you think you have been exposed to coronavirus after you collect, get tested after the event, Ferrer said.

“Someone I know took a quick COVID test before visiting a severely immunocompromised person. They were asymptomatic except for ‘allergy symptoms’.” tweeted Dr. Jeremy Faust, an emergency physician at Brigham and Women’s Hospital and an instructor at Harvard Medical School.

“The test was taken solely to protect the victim. It was positive,” Faust wrote. “Rapid testing of asymptomatic people saves lives.”

Quick corona tests at home can be purchased at pharmacies and at online retailers.

Insured persons also have the option of ordering eight home tests per month for each person covered on their health plan and having them reimbursed by their health care provider. The US government began demands insurance companies to reimburse the samples beginning in mid-January.

In addition, every household in the United States is eligible to receive two sets of four home tests sent to them free of charge. People can order these samples at covidtests.gov or by calling (800) 232-0233. Many people ordered their first set of tests in January or February; the government allowed households to request another set of free tests in March.

Gather outside whenever possible and if not, open the windows

Keeping assemblies outside reduces the risk of infection, Ferrer said.

“When that’s not possible, it’s best to have the assemblies small. And you can improve the indoor airflow by opening windows, doors and using fans strategically,” Ferrer said.

Wear a mask in an indoor public setting

Although no longer required, Ferrer and state public health officials have continued to strongly recommend wearing masks in indoor public environments. Respirators, such as KF94, KN95 and N95 masks, provide better protection.

If you test positive and you are at high risk, seek an anti-COVID medicine

Anti-COVID drugs are available for those who test positive and are at high risk, but it is important that you know your coronavirus test status early in the infection and seek the drugs right away.

For people who test positive, state health officials say there is no longer a shortage of anti-COVID drugs in most places.

“At this time, all outpatients with mild to moderate COVID-19 who are at risk for disease progression should be offered treatment if they are eligible,” California Department of Public Health said recently. People can seek prescriptions by calling their doctor.

The US government has launched a “Test to Treat” program that allows people to be tested and get free anti-COVID pills in the same place, such as a pharmacy or clinic, as long as staff can either perform a coronavirus. test or evaluate a test results at home and have doctors on site who can assess the patient.

A list of sites that offer “Test to Treat” services in LA County can be found at ph.lacounty.gov/covidmedicines or by calling the County Department of Public Health at (833) 540-0473 between 8 a.m. and 8:30 p.m., seven days a week. They include certain CVS and Walgreens locations as well as hospitals, clinics and local pharmacies. A resident of LA County with a positive test can also have the drugs sent to them at no cost by calling the same number.

For a LA County resident: “If you have a test kit at home and you test yourself and you are positive, you can call us. We will have a provider or clinician talk to you, make an assessment. If “You are entitled, you will be sent that medicine overnight, so you will receive it the very next day,” Ferrer said.

“Test to Treat” locations outside of LA County can be found at aspr.hhs.gov/TestToTreat.

The antiviral pills offered in the program are Paxlovidmanufactured by Pfizer, and molnupiravir, made by Merck & Co., which treats mild to moderate COVID-19. The drugs should be given within a certain number of days after the onset of symptoms, or from the day of a positive coronavirus test, and they work best if given early.

According to federal guidelines, Paxlovid and molnupiravir are recommended to patients “at high risk of developing severe COVID-19”, but can only be given to those who are not so ill that they need hospitalization or supplemental oxygen therapy.

Another drug that is not in the “Test to Treat” program but available as an anti-COVID drug is bebtelovimab, which is in a class of drugs called monoclonal antibodies.

Bebtelovimab is for use in people 12 years of age and older who have been tested positive for coronavirus, are at high risk, and for whom other treatment options are not available or appropriate. It should also be given as an injection over at least 30 minutes.

Another anti-COVID drug – remdesivir – is given intravenously, but it is in the class of medicines known as antiviral drugs.

Remdesivir is administered intravenously in a slow infusion over 30 minutes to two hours in a hospital. For non-hospitalized patients, it is given once daily for three days and started within seven days after the first symptoms; for inpatients with severe COVID-19, it is typically administered once daily for five to 10 days.

Unlike the anti-COVID drugs available as pills, remdesivir is the only antiviral drug that can be used to treat children. under 12 yearsas long as they weigh at least 7.7 pounds.

The U.S. Food and Drug Administration said so preferred therapies is first Paxlovid and then remdesivir. When none of them are available or feasible to use, the FDA says that bebtelovimab and molnupiravir can be considered as alternatives.


Leave a Reply

Your email address will not be published.